Pamela Boneham Joins Ventas Investment Management Platform as Senior Strategic Advisor
June 22 2022 - 10:30AM
Business Wire
Ventas, Inc. (NYSE: VTR), a leading real estate investment trust
(REIT), announced today that it has appointed Pamela Boneham as a
Senior Strategic Advisor to its Ventas Investment Management (VIM)
Platform.
In this role, Boneham will provide experienced advice and
guidance across Ventas’s institutional third-party investment
management platform, currently with over $5 billion in assets under
management, including the Ventas Life Science & Healthcare Real
Estate Fund. Leveraging Ventas’s expertise, VIM is focused on
investing in high quality life science, medical office, senior
housing and other healthcare real estate for third-party
institutional investors in a variety of vehicles.
“We are delighted to welcome Pam as a senior strategic advisor
to Ventas’s Investment Management platform. Her decades of
accomplishment in commercial real estate and deep understanding of
institutional investors’ perspectives and objectives will be
invaluable to our continued growth and value creation,” said Brian
Newman, Senior Vice President and Portfolio Manager, Ventas.
Boneham commented, “I am delighted to join the Ventas Investment
Management platform, which is off to an outstanding start. I look
forward to making significant contributions as it becomes a more
established and influential participant in the investment
management business focused on high-quality life science, medical
office and other healthcare real estate.”
Boneham currently serves as an Independent Investment Committee
Member for CBRE Investment Management’s Americas Direct Real Estate
Investment Committee and for City of Hope, a world-class non-profit
cancer care hospital headquartered in Southern California. She has
over 35 years of experience in commercial real estate and the
institutional investment advisory business, having held senior
roles with Barings, from which she recently retired, RREEF/DWS,
Equity Office and JLL. Boneham holds an MBA from the University of
Wisconsin-Madison and graduated summa cum laude with a BBA from the
University of Wisconsin-Whitewater.
About Ventas
Ventas Inc., an S&P 500 company, operates at the
intersection of two large and dynamic industries – healthcare and
real estate. Fueled by powerful demographic demand from growth in
the aging population, Ventas owns a diversified portfolio of over
1,200 properties in the United States, Canada, and the United
Kingdom. Ventas uses the power of its capital to unlock the value
of senior living communities; life science, research &
innovation properties; medical office & outpatient facilities,
hospitals and other healthcare real estate. A globally recognized
real estate investment trust, Ventas follows a successful long-term
strategy, proven over more than 20 years, built on diversification
of property types, capital sources and industry leading partners,
financial strength and flexibility, consistent and reliable growth
and industry leading ESG achievements, managed by a collaborative
and experienced team dedicated to its stakeholders.
About VIM
Ventas Investment Management consolidates the company’s
third-party capital ventures under a single umbrella. Within the
$16 trillion commercial real estate industry, approximately 20
percent is owned by public entities, while the remaining 80 percent
is in the hands of private investors. VIM enables Ventas to access
this expansive market opportunity by attracting global private
capital to its demographically driven asset classes. Private owners
of real estate seek to invest alongside Ventas directly in life
science, senior housing and other healthcare real estate to obtain
the benefit of Ventas’s experience, relationships and industry
knowledge. With more than $5 billion in assets under management,
the VIM platform includes the Ventas Life Science & Healthcare
Real Estate Fund, a life science development joint venture with GIC
and its senior housing development State Pension Fund joint
venture. VIM enables Ventas to expand its footprint, diversify its
capital sources, augment its investment capacity, accelerate its
development and acquisition pipeline and generate additional
recurring revenue and profit opportunities, all by leveraging its
team and infrastructure.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220622005281/en/
BJ Grant, (877) 4-VENTAS
Ventas (NYSE:VTR)
Historical Stock Chart
From Sep 2024 to Oct 2024
Ventas (NYSE:VTR)
Historical Stock Chart
From Oct 2023 to Oct 2024